Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Jefferies London Healthcare Conference Transcript

Nov 21, 2019 / 09:20AM GMT
Release Date Price: $140.07 (+0.39%)
David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst

Good morning, everybody. Welcome back. Thank you for being here at our London -- 2019 London Healthcare Conference. I'm Dave Windley with Jefferies. I cover a variety of health care sectors, including the contract research organization sector, and that is the sector where our next company competes. That will be Charles River Laboratories. And to present for them is the company's Chief Financial Officer -- Executive VP and Chief Financial Officer, David Smith. He's going to present their presentation, and then we think we'll have a few minutes at the end for some Q&A, but I'll turn it over to David for that presentation. Thanks for being here.

David Ross Smith
Charles River Laboratories International, Inc. - Corporate Executive VP & CFO

Okay. Good morning. I'm based in Boston, but as you can tell from my accent, I'm British. So if you are interested in following Charles River with one-on-ones, if you reach out to Todd Spencer, who's in-charge of our Investor Relations, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot